DBV Technologies | Créances Commerciales





Créances Commerciales Changement Date
Acadia Pharmaceuticals USD 148.23M 8.79M 2025-12
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amarin USD 127.31M 8.18M 2025-09
BioCryst Pharmaceuticals USD 79.07M 6.61M 2024-12
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
DBV Technologies USD 15.97M 279K 2025-09
Esperion Therapeutics USD 60.36M 5.75M 2024-06
Halozyme Therapeutics USD 441.27M 95.24M 2025-12
Incyte USD 1.02B 128.52M 2025-12
Insmed USD 140.86M 75.6M 2025-12
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
PTC Therapeutics USD 181.62M 21.45M 2025-12
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
United Therapeutics USD 350.2M 52.5M 2025-12


DBV Technologies Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.